Prestige Consumer Healthcare Inc.
PBH | NYSE
$46.80
+$1.83 (+4.07%)
At close: Sep 21, 2026, 4:00 PM ET
$46.80
$0 (0.00%)
After-hours:
Sep 21, 2026, 4:00 PM ET
Company Profile
Prestige Consumer Healthcare Inc., along with its various divisions, is involved in the creation, production, promotion, and distribution of non-prescription health and personal care items across both domestic (U.S.) and global markets. The company's business activities are structured into two principal areas: North American Over-the-Counter Healthcare and International Over-the-Counter Healthcare. Their extensive brand catalog features a diverse array of consumer health solutions, including popular choices for pain relief (such as BC/Goody's), infant care (Boudreaux's Butt Paste), sore throat remedies (Chloraseptic), vision care (Clear Eyes, TheraTears), wart treatment (Compound W), dental hygiene (DenTek), earwax removal (Debrox), and motion sickness prevention (Dramamine). The product line further extends to include digestive aids (Fleet, Gaviscon), cough suppressants (Luden's), feminine hygiene items (Monistat, Summer's Eve), treatments for lice and parasites (Nix), nasal washes (Fess), and rehydration therapies (Hydralyte). These offerings reach consumers through a wide range of retail channels, such as large discount retailers, pharmacies, supermarkets, dollar stores, convenience outlets, membership-based clubs, and digital commerce platforms. Founded in 1996 and based in Tarrytown, New York, the organization operated under the name Prestige Brands Holdings, Inc. until its rebranding to Prestige Consumer Healthcare Inc. in August 2018.
Key Executives
| Name | Position |
|---|---|
| Ronald Lombardi | Chairman, President & Chief Executive Officer |
| Christine Sacco | Chief Financial Officer & Chief Operating Officer |
| Adel Mekhail | Executive Vice President of Marketing & Sales |
| Dean Siegal | Director of Communications |
| Jeffrey Zerillo | Senior Vice President of Operations |
| Jose Luis Rosado | Senior Vice President of Quality & Regulatory Affairs |
| Philip David Terpolilli | Director of Investor Relations |
| William C. P'Pool | Senior Vice President, General Counsel & Corporate Secretary |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 14, 2026 | 8-K | Current Report |
| Aug 06, 2026 | 10-Q | Quarterly Report |
| Aug 06, 2026 | 8-K | Current Report |
| Aug 05, 2026 | 4 | Filing |
| Aug 05, 2026 | 4 | Filing |
| Aug 05, 2026 | 4 | Filing |
| Aug 05, 2026 | 4 | Filing |
| Aug 05, 2026 | 4 | Filing |
| Jul 15, 2026 | 8-K | Current Report |
| Jul 09, 2026 | 8-K/A | [Amend] Current Report |
Prestige Consumer Healthcare Inc.
| Country | United States |
| IPO Date | Feb 9, 2005 |
| Industry | Medical - Pharmaceuticals |
| Sector | Healthcare |
| Employees | 890 |
| CEO | Ronald Lombardi |
Contact Details
660 White Plains Road Tarrytown,
New York 10591 United States
Stock Details
| Ticker Symbol | PBH |
| Exchange | NYSE |
| Fiscal Year | April - March |
| Reporting Currency | USD |
| CIK Code | 0001295947 |
| CUSIP Number | 74112D101 |
| ISIN Number | US74112D1019 |
| SIC Code | 2834 |
Recent News
- 8 days ago / zacks.comPBH or NEOG: Which Is the Better Value Stock Right Now?
- 12 days ago / seekingalpha.comPrestige Consumer Healthcare Inc. (PBH) Presents at Barclays 19th Annual Global Consumer Staples Conference Transcript
- 21 days ago / prnewswire.comFootball Stress May Be Following Fans to Bed, According to the Inaugural DenTek® Football Stress Test
- 25 days ago / zacks.comPBH vs. SYK: Which Stock Is the Better Value Option?
- 1 month ago / foxbusiness.comNearly 40,000 eye drops recalled nationwide over possible contamination
- 1 month ago / seekingalpha.comAmylyx: Upgraded To Strong Buy On LUCIDITY Outcome, Avexitide, And 2026 Catalysts
- 1 month ago / zacks.comPBH or SYK: Which Is the Better Value Stock Right Now?
- 1 month ago / marketbeat.comPremium Brands Q2 Earnings Call Highlights
- 2 months ago / seekingalpha.comPrestige Consumer Healthcare Inc. (PBH) Q1 2027 Earnings Call Transcript
- 2 months ago / zacks.comPrestige Consumer Healthcare (PBH) Q1 Earnings and Revenues Surpass Estimates
Add to Watchlist
Select watchlists to add or remove PBH